2-sulfinyland 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors

Details for Australian Patent Application No. 2006218037 (hide)

Owner Merckle GmbH

Inventors Greim, Cornelia; Laufer, Stefan; Tollmann, Karola; Merckle, Philipp; Albrecht, Wolfgang; Striegel, HansGunter

Agent Freehills

Pub. Number AU-B-2006218037

PCT Pub. Number WO2006/089798

Priority 60/656,389 28.02.05 US; 05004369.4 28.02.05 EP

Filing date 27 February 2006

Wipo publication date 31 August 2006

Acceptance publication date 5 April 2012

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/089798 Priority application(s): WO2006/089798

5 April 2012 Application Accepted

  Published as AU-B-2006218037

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006218043-Aqueous topical gel of high stability based on metronidazole and method of preparation

2006218034-Monitoring device for windows and doors